| 0.9901 -0.1 (-9.17%) | 10-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.5 | 1-year : | 1.79 |
| Resists | First : | 1.29 | Second : | 1.53 |
| Pivot price | 1.17  |
|||
| Supports | First : | 0.88 | Second : | 0.74 |
| MAs | MA(5) : | 1.11 |
MA(20) : | 1.15 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1  |
| %K %D | K(14,3) : | 14.9 |
D(3) : | 26.4 |
| RSI | RSI(14): 38.6 |
|||
| 52-week | High : | 3.17 | Low : | 0.88 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PASW ] has closed above bottom band by 2.0%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 1.05 - 1.06 | 1.06 - 1.06 |
| Low: | 0.96 - 0.96 | 0.96 - 0.97 |
| Close: | 0.98 - 0.99 | 0.99 - 1 |
A holding company (formerly covering apparel supply chain management) that is rebranding to focus on biomedical / health-biotech business. Its historical operations included supply chain, yarn/textiles, garments, logistics in apparel SCM.
Fri, 26 Sep 2025
Majestic Ideal Holdings to become Ping An Biomedical with new Nasdaq ticker - Investing.com
Fri, 26 Sep 2025
Majestic Ideal Holdings Ltd Rebrands to Ping An Biomedical Co., Ltd. - TipRanks
Fri, 12 Sep 2025
Majestic Ideal Holdings to rebrand as Ping An Biomedical - Investing.com
Fri, 12 Sep 2025
Majestic Ideal shareholders approve name change to Ping An Biomedical - Investing.com
Fri, 18 Jul 2025
Majestic Ideal debuts below IPO price on Nasdaq - Investing.com
Thu, 17 Jul 2025
Majestic Ideal prices IPO at $6 per share, set to debut on Nasdaq - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 66.4 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.65 |
| Profit Margin | -9.6 % |
| Operating Margin | -19.9 % |
| Return on Assets (ttm) | -4.6 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -60.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 11 (M) |
| Levered Free Cash Flow | 51 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -1.53 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|